GIST KALK APK

5+ votes, 4.00/5

... [readmore]


⇣ Download APK (363.92 KB)

This is an original APK file direct fetch from google play. It is safe to download and free of any virus.

Version 1.0.7
Update
Size 363.92 KB
Category Medical
Developer Via Medica
Downloads ↓ 0
⇣ Download APK (363.92 KB)

This is an original APK file direct fetch from google play. It is safe to download and free of any virus.

File Infos

License type Free
Version 1.0.7
Size 363.92 KB (372650)
Filename pl.prounity.gist.android_7_372650.apk
Requirement 2.2 and up
Type app
Category Medical
Package name: pl.prounity.gist.android
Slogan:

APK Permissions


‣ 


APK used Features


‣ android.hardware.touchscreen

Screenshots (6 images)

GIST KALK screenshot 1 GIST KALK screenshot 2 GIST KALK screenshot 3 GIST KALK screenshot 4 GIST KALK screenshot 5 GIST KALK screenshot 6

About GIST KALK APK

GIST KALK poster
GIST KALK APK version 1.0.7 poster

Latest update [menu]


Drobne poprawki

Description [menu]


GIST KALK - Kalkulator oceny ryzyka nawrotu u chorych po resekcji pierwotnego nowotworu podścieliskowego przewodu pokarmowego (GIST).

GIST - Kalkulator skierowany jest do lekarzy. Pozwala dokonać oceny ryzyka nawrotu u chorych po resekcji pierwotnego nowotworu podścieliskowego przewodu pokarmowego (GIST) - grupy rokownicze o różnych lokalizacjach wg wytycznych ESMO, 2012.

Jak obliczyć ryzyko nawrotu u chorych po resekcji pierwotnego nowotworu podścieliskowego przewodu pokarmowego (GIST)?

Obliczenia powstają poprzez wybranie przycisków w trzech grupach:
1. Liczba mitotyczna - (HPF - ang: High Power Field - pole w dużym powiększeniu w mikroskopie x 400)
2. Wielkość guza - centymetry
3. Lokalizacja guza (żołądek, dwunastnica, jelito czcze i kręte, odbytnica)

Wynik podawany jest jako odsetek nawrotów po leczeniu chirurgicznym w ramach grup rokowniczych. GIST KALK - Calculator assess the risk of recurrence in patients after resection of primary gastrointestinal stromal tumor (GIST).

GIST - Calculator is intended for doctors. This allows to assess the risk of recurrence in patients after resection of primary gastrointestinal stromal tumor (GIST) - prognostic groups in different locations by ESMO Guidelines, 2012.

How to calculate the risk of recurrence in patients after resection of primary gastrointestinal stromal tumor (GIST)?

Calculations are made by selecting the buttons in three groups:
First Number of Mitotic - (HPF - ang: High Power Field - the field at high magnification microscope x 400)
Second Tumor size - centimeters
3rd Location of the tumor (stomach, duodenum, jejunum and ileum, rectum)

The result is given as a percentage of recurrence after surgery in the prognostic groups.

How to install GIST KALK APK for Android [menu]


Download GIST KALK APK file (pl.prounity.gist.android_7_372650.apk) from SameAPK.com, then follow these steps:

Update Phone Settings

  • Go to your phone Settings page
  • Tap Security or Applications (varies with device)
  • Check the Unknown Sources box
  • Confirm with OK

Go to Downloads

  • Open Downloads on your device by going to My Files or Files
  • Tap the APK file you downloaded (pl.prounity.gist.android_7_372650.apk)
  • Tap Install when prompted, the APK file you downloaded will be installed on your device.

How to install GIST KALK APK on Windows 7/8/10 or MAC PC? [menu]


Download GIST KALK APK file(pl.prounity.gist.android_7_372650.apk) from SameAPK.com to your PC (ex: /Users/xxx/Downloads/(pl.prounity.gist.android_7_372650.apk)), then follow these steps:

Using Emulator:

  • Download And Install one Emulator Softwares (Ex: Bluestacks, GenyMotion, NoxPlayer)
  • Simple install APK on PC by drag and drop file pl.prounity.gist.android_7_372650.apk on Emulator screen

GIST KALK APK Pros & Cons [menu]


Pros
  • This app is safe, it's not require high risk permissions
  • Compatible with 32 bit device (most Emulator using 32bit arch CPU)
  • Compatible with 64-bit device (some android device and current Bluestacks)

Cons
Everything is good.


Similar applications [menu]


New Apps



Comments

No comment Yet.